<p>(A) Left, change of ALT level after ADV treatment. Right, the decrease in ALT levels of the genotype shift (GS) group was significantly higher than group without genotype shift (NS) (<i>p</i> <0.05). (B) Left, comparison of HBeAg seroconversion after ADV treatment between the GS group and the NS group (<i>p</i> >0.05). Right, comparison of HBeAg seroclearance after ADV treatment between the GS group and the NS group(<i>p</i> >0.05). (C)Left, change of HBV DNA load after ADV treatment. Right, the reduction of HBV DNA load in GS group and NS group did not different significantly (<i>p</i> >0.05).</p
<p>*Other mutations in the preCore region that abolish HBeAg expression. No significant difference w...
**<p>The difference of DD % with other patient groups is significant (P<0,02).</p
<p>Comparison of HBV genotype A and genotype D infected donors with demographic and laboratory profi...
<div><p>Background</p><p>Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral...
Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reporte...
<p>(A) Genotype distributions of 13 patients with genotype shift observed by clonal sequencing showe...
Background Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has b...
We investigated whether HBV genotype influences on-treatment HBsAg kinetics and/or the end-of-treatm...
<p>Mean HBV DNA and qHBsAg during PegIFN therapy in patients stratified by <i>CYP2R1</i> rs12794714 ...
<p>(A) VHB genotype A, Abbott <i>ρ</i> = 0.44, p = 0.02; Diasorin <i>ρ</i> = 0.49, p = 0.01; Bio-Rad...
<p>Each dot represents the HBV DNA load of a clinical sample at baseline. The horizontal lines indic...
<p>A. Average number of mutations nucleotides in BCP/precore region in children and adultpatients wi...
<p>(A) Plots of predicted mean plasma HBV-DNA levels derived from LOESS for each year of follow-up t...
<p>HBV DNA levels in HBeAg sero-positive and HBeAg sero-negative groups among patients without pre-e...
<p>(<b>A</b>) Determination of HBV loads of the predominant HBV-genotype A and HBV-genotype C sample...
<p>*Other mutations in the preCore region that abolish HBeAg expression. No significant difference w...
**<p>The difference of DD % with other patient groups is significant (P<0,02).</p
<p>Comparison of HBV genotype A and genotype D infected donors with demographic and laboratory profi...
<div><p>Background</p><p>Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral...
Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has been reporte...
<p>(A) Genotype distributions of 13 patients with genotype shift observed by clonal sequencing showe...
Background Viral genotype shift in chronic hepatitis B (CHB) patients during antiviral therapy has b...
We investigated whether HBV genotype influences on-treatment HBsAg kinetics and/or the end-of-treatm...
<p>Mean HBV DNA and qHBsAg during PegIFN therapy in patients stratified by <i>CYP2R1</i> rs12794714 ...
<p>(A) VHB genotype A, Abbott <i>ρ</i> = 0.44, p = 0.02; Diasorin <i>ρ</i> = 0.49, p = 0.01; Bio-Rad...
<p>Each dot represents the HBV DNA load of a clinical sample at baseline. The horizontal lines indic...
<p>A. Average number of mutations nucleotides in BCP/precore region in children and adultpatients wi...
<p>(A) Plots of predicted mean plasma HBV-DNA levels derived from LOESS for each year of follow-up t...
<p>HBV DNA levels in HBeAg sero-positive and HBeAg sero-negative groups among patients without pre-e...
<p>(<b>A</b>) Determination of HBV loads of the predominant HBV-genotype A and HBV-genotype C sample...
<p>*Other mutations in the preCore region that abolish HBeAg expression. No significant difference w...
**<p>The difference of DD % with other patient groups is significant (P<0,02).</p
<p>Comparison of HBV genotype A and genotype D infected donors with demographic and laboratory profi...